Oprah Winfrey’s Decision to Abandon Traditional Weight Loss Treatments in Favor of Pharmaceutically Driven Options Will Likely Accelerate Prescription Flows for Novo Nordisk and Eli Lilly.
Oprah Winfrey’s public statements, and decision to step away from the Weight Watcher’s brand, is as clear an indication of the shift away from lifestyle choices towards weight management, in favor of pharmaceutical options, as can be intimated. There really…
Posted in Open Blog